CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 | ₹19.18 |
What is the latest Earnings Per Share (EPS) of CIPLA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹51.05 |
| Mar2024 | ₹34.71 |
| Mar2023 | ₹31.19 |
| Mar2022 | ₹29.82 |
| Mar2021 | ₹19.18 |
How is Earnings Per Share (EPS) of CIPLA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹51.05 | 47.08 | |
| Mar2024 | ₹34.71 | 11.29 | |
| Mar2023 | ₹31.19 | 4.59 | |
| Mar2022 | ₹29.82 | 55.47 | |
| Mar2021 | ₹19.18 | - | |
Compare Earnings Per Share (EPS) of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,414.8 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹85,533.2 Cr | -0.9% | -5.8% | -18.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.3% |
-8.5% |
-7.3% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses